Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Weekly Infusions of JR-441 in Patients With Mucopolysaccharidosis Type IIIA

NCT06095388 is registered in ClinicalTrials.gov with JCR Pharmaceuticals Co., Ltd. as lead sponsor.

NCT NCT06095388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06095388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Weekly Infusions of JR-441 in Patients With Mucopolysaccharidosis Type IIIA
Lead sponsor
JCR Pharmaceuticals Co., Ltd.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
October 4, 2023
Completion date
October 31, 2029
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mucopolysaccharidosis iii-a